Pfizer Inc (PFE)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	50,358,000	43,223,000	37,825,000	42,415,000	43,333,000	74,012,000	73,347,000	50,078,000	51,259,000	70,403,000	67,466,000	54,420,000	59,693,000	57,900,000	48,814,000	39,533,000	35,067,000	47,739,000	46,424,000	34,738,000
Total current liabilities	US$ in thousands	42,995,000	43,211,000	43,819,000	40,497,000	47,794,000	31,136,000	34,647,000	36,562,000	42,138,000	44,314,000	47,410,000	39,268,000	42,671,000	41,803,000	35,664,000	26,652,000	25,920,000	34,154,000	32,723,000	33,890,000
Current ratio		1.17	1.00	0.86	1.05	0.91	2.38	2.12	1.37	1.22	1.59	1.42	1.39	1.40	1.39	1.37	1.48	1.35	1.40	1.42	1.03

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $50,358,000K ÷ $42,995,000K
= 1.17

Pfizer Inc's current ratio provides insight into the company's ability to cover its short-term obligations using its current assets. A higher current ratio indicates stronger short-term liquidity.

The current ratio of Pfizer Inc fluctuated over the reported periods. It was relatively stable around 1.3 to 1.5 for most of the periods, suggesting the company maintained a healthy position to meet its short-term obligations with its current assets. The ratio peaked at 2.38 as of September 30, 2023, indicating a significant increase in short-term liquidity.

However, the current ratio declined notably to 0.91 as of December 31, 2023, indicating a potential strain on the company's ability to cover short-term liabilities with current assets. This may warrant further analysis to understand the reasons behind the decrease and whether it represents a temporary or more concerning trend.

The subsequent periods showed some recovery in the current ratio, although it remained below the levels seen in earlier periods. The ratio on December 31, 2024, was reported at 1.17, indicating a slight improvement in short-term liquidity compared to the previous quarter.

Overall, while Pfizer Inc demonstrated varying levels of short-term liquidity over the reported periods, the company generally maintained a current ratio above 1, indicating a reasonable ability to meet its short-term obligations with its current assets.